How to Measure Knockout Efficiency in a Cell Pool
The Short Answer
Sequence the amplicon. In a pool, amplicon NGS gives the allele distribution — indels, wild type, and larger events — and that distribution is the measurement. A single efficiency number hides the part that matters: whether the indels actually disrupt the protein.
Fast alternatives (Sanger plus ICE/TIDE, restriction digest) are acceptable for triage; they are not sufficient for a claim.
Why "Efficiency" Is the Wrong Single Number
Three pools can all report "70% editing" and behave completely differently:
- • One has 70% frameshift indels — effectively a knockout.
- • One has 70% in-frame indels — partial loss of function at best.
- • One has 70% edited alleles spread across many distinct indels, some of which remove an exon and some of which change one codon.
In cell pools, the practical consequence is that the phenotype you measure is a weighted average over these alleles. Reporting the spectrum, not just the rate, is what makes the result interpretable.
Methods Compared
| Method | Output | Best use | Limitation |
|---|---|---|---|
| Amplicon NGS | Allele frequencies, indel spectrum | Definitive measurement | Requires primers and depth |
| Sanger + ICE/TIDE | Estimated indel fraction and spectrum | Quick triage | Poor resolution below ~10%; fails on complex alleles |
| Digital PCR drop-off | Fraction with a specific edit | Quantifying a known edit | Blind to other alleles |
| Restriction digest | Loss of a site | Very cheap screening | Only for edits that destroy a site |
| Functional readout | Phenotype | Biological relevance | Conflates editing with downstream biology |
Practical Details That Change the Answer
- • Primer placement. Amplicons must cover the cut site with enough flanking sequence to detect larger deletions; amplicons that are too short miss them.
- • Depth. A few thousand reads per sample is adequate for allele frequencies; low depth systematically under-reports rare alleles.
- • Timing. Measure 72 hours or more after editing — early timepoints under-report because editing continues.
- • Cell number. Sequence from a defined number of cells, not from a fraction of the culture, so that the measurement is comparable across arms.
From Pool to Clone
A pool measurement tells you whether the editing strategy works; it does not tell you what any individual clone contains. Before making claims, move to clones and sequence each one — the pool distribution is a planning tool, not a result.
A useful workflow: pool amplicon sequencing to confirm the guide and editing conditions, then clone and sequence 24–96 clones, then select two or more with confirmed null alleles for experiments.
Reporting
State the method, the amplicon coordinates, the read depth, the timing after editing, and the allele spectrum (top alleles with frequencies), plus the fraction of in-frame versus frameshift events. That combination lets a reader judge whether "knockout" is the right word.
Need pool and clone-level QC?
EDITGENE reports amplicon sequencing at pool and clone level, with allele spectra, in-frame versus frameshift classification, and zygosity by digital PCR.
Tell us the target and the cell line. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Editing efficiency depends on locus, guide, delivery, and cell type; a pool measurement describes the distribution in that specific experiment.
Indel frequency is not knockout frequency: in-frame indels may retain function, and protein-level confirmation is required for a null claim.
Selected references for further reading
- • Brinkman EK, et al. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Research. 2014;42:e168.
- • Vouillot L, et al. Comparison of T7E1 and surveyor mismatch cleavage assays. G3. 2015;5:407–415.
- • Sentmanat MF, et al. A survey of validation strategies for CRISPR-Cas9 editing. Scientific Reports. 2018;8:888.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »